Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program

Objective: to investigate the efficacy and safety of Cavinton® Comforte (Vinpocetine) in patients with initial manifestations of chronic cerebrovascular disease (CVD) in outpatient neurological and therapeutic practice.Patients and methods. The program included 4410 patients with a verified diagnosi...

Full description

Bibliographic Details
Main Authors: G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2017-11-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/770